10000|10000|Public
5|$|The human {{dopamine}} transporter {{contains a}} high affinity extracellular zinc <b>binding</b> <b>site</b> which, upon zinc binding, inhibits dopamine reuptake and amplifies amphetamine-induced dopamine efflux in vitro. <b>binding</b> <b>site</b> with three coordinating residues on its extracellular face (His193, His375, and Glu396).... Thus, when Zn2+ is co-released with glutamate, it may greatly augment the efflux of dopamine.}} The human serotonin transporter and norepinephrine transporter {{do not contain}} zinc binding sites.|$|E
5|$|When {{an enzyme}} has {{multiple}} substrates, inhibitors can show {{different types of}} inhibition depending on which substrate is considered. This results from the active site containing two different binding sites within the active site, one for each substrate. For example, an inhibitor might compete with substrate A for the first <b>binding</b> <b>site,</b> but be a non-competitive inhibitor with respect to substrate B in the second <b>binding</b> <b>site.</b>|$|E
5|$|The CD155 gene {{appears to}} have been subject to {{positive}} selection. The protein has several domains of which domain D1 contains the polio virus <b>binding</b> <b>site.</b> Within this domain, 37 amino acids are responsible for binding the virus.|$|E
40|$|The {{effect of}} phenylhydrazine-induced heart {{hypertrophy}} on muscarinic cholinergic <b>binding</b> <b>sites</b> was studied in heart membranes by determining total (with [3 H]NMS) and high-affinity (with [3 H]Oxo-M) <b>binding</b> <b>sites</b> and estimating low-affinity <b>binding</b> <b>sites</b> by difference. Phenylhydrazine induced an increased concentration of high-affinity <b>binding</b> <b>sites</b> without affecting {{the concentration of}} low-affinity <b>binding</b> <b>sites.</b> The KD values for the ligands were unaffected. Journal ArticleResearch Support, Non-U. S. Gov'tinfo:eu-repo/semantics/publishe...|$|R
40|$|Ahstraet-We have {{investigated}} the cellular localization of cerebellar excitatory amino acid <b>binding</b> <b>sites</b> in normal mice, in mice deficient in granule cells and, perhaps, stellate, basket and Golgi cells (granuloprival mice) and in mioe lacking Purkinje cells. in the molecular layer of normal mouse oerebelhun, the q~~~a~-~n~ti ~ <b>binding</b> <b>sites</b> were the predominant ype of excitatory amino acid reoeptor and there were relatively few ~-me~yl-pupate or ~~t~~~tive <b>binding</b> <b>sites.</b> The granule cell layer of notmal mice contained a mixture of all 3 types, the N-methyl-n-aspartate-sensitive <b>binding</b> <b>sites</b> being predominant. In the molecular layer of granuloprival mice, the number of quisqualate-sensitive <b>binding</b> <b>sites</b> was increased to 214 % of control (P <t& 01), whereas N-methyl-n-aspartate-sensitive <b>binding</b> <b>sites</b> were M to 62 % of control (P <O. OOl) and kainate-sensitive <b>binding</b> <b>sites</b> were unchanged. In the granule cell layer of these mice, quisqualate-sensitive <b>binding</b> <b>sites</b> were increased to 200 % (P < 0. 01). ~-~~yl-~~~sitive <b>binding</b> <b>sites</b> were decreased to 47 % (P < 0. 001) and kainate-sensitive <b>binding</b> <b>sites</b> wem decmaaed to 49 % (P < 0. 01) of their respective control values. in the molecular layer of mice lacking Purkinje cells, quisqualate-sensitive <b>binding</b> <b>sites</b> were reduced to 29 % (P < 0. 001) of control and N-methyl-D-aspartatsensitive <b>binding</b> <b>sites</b> were unchanged. In th...|$|R
40|$|The {{effects of}} the thyroid state and of aortic {{stenosis}} on muscarinic cholinergic <b>binding</b> <b>sites</b> in heart membranes were compared (with proper controls) by simultaneously determining total and high-affinity <b>binding</b> <b>sites</b> and estimating low-affinity <b>binding</b> <b>sites</b> by difference. Hyper- and hypothyroidism induced decreased and increased concentration of high-affinity agonist <b>binding</b> <b>sites,</b> respectively, supporting the hypothesis that these sites were directly regulated by thyroid hormones. This {{was not the case}} for low-affinity <b>binding</b> <b>sites,</b> as they decreased in number in both hyper- and hypothyroidism. In hyperthyroid rats, this decreased number of low-affinity <b>binding</b> <b>sites</b> could be due to the rapidly developing cardiac hypertrophy. Indeed, cardiac hypertrophy provoked by aortic stenosis led also to a decreased concentration of low-affinity <b>binding</b> <b>sites</b> without affecting the concentration of high-affinity <b>binding</b> <b>sites.</b> In VitroJournal ArticleResearch Support, Non-U. S. Gov'tinfo:eu-repo/semantics/publishe...|$|R
5|$|A C-terminal domain (489-561 {{amino acids}} in human EFS) is highly conserved between family members at both primary amino acid {{sequence}} and predicted fold. All CAS proteins except CASS4 contain a YDYVHL motif within this domain, which is an important <b>binding</b> <b>site</b> for the Src SH2 domain. This region is considered to possess a homo- or heterodimerization ability.|$|E
5|$|Non{{benzodiazepine}}s also bind to the benzodiazepine <b>binding</b> <b>site</b> on the GABAA receptor and possess similar pharmacological properties. While the nonbenzodiazepines are {{by definition}} structurally {{unrelated to the}} benzodiazepines, both classes of drugs possess a common pharmacophore (see figure to the lower-right), which explains their binding to a common receptor site.|$|E
5|$|The {{transcribed}} pre-mRNA contains untranslated regions at {{both ends}} which contain a ribosome <b>binding</b> <b>site,</b> terminator and start and stop codons. In addition, most eukaryotic open reading frames contain untranslated introns which are removed before the exons are translated. The sequences {{at the ends of}} the introns, dictate the splice sites to generate the final mature mRNA which encodes the protein or RNA product.|$|E
40|$|We have {{investigated}} the cellular localization of cerebellar excitatory amino acid <b>binding</b> <b>sites</b> in normal mice, in mice deficient in granule cells and, perhaps, stellate, basket and Golgi cells (granuloprival mice) and in mice lacking Purkinje cells. In the molecular layer of normal mouse cerebellum, the quisqualate-sensitive <b>binding</b> <b>sites</b> were the predominant type of excitatory amino acid receptor and there were relatively few N-methyl [...] aspartate or kainate-sensitive <b>binding</b> <b>sites.</b> The granule cell layer of normal mice contained a mixture of all 3 types, the N-methyl [...] aspartate-sensitive <b>binding</b> <b>sites</b> being predominant. In the molecular layer of granuloprival mice, the number of quisqualate-sensitive <b>binding</b> <b>sites</b> was increased to 214 % of control (P P P P P In the molecular layer of mice lacking Purkinje cells, quisqualate-sensitive <b>binding</b> <b>sites</b> were reduced to 29 % (P These results suggest that (1) quisqualate-sensitive <b>binding</b> <b>sites</b> are located principally on dendrites of Purkinje cells and that they up-regulate after deafferentation; (2) N-methyl [...] aspartate-sensitive <b>binding</b> <b>sites</b> are located on granule cells and, perhaps, stellate, basket and Golgi cells, and (3) kainate <b>binding</b> <b>sites</b> are located on cell bodies of granule and, perhaps, Golgi cells...|$|R
40|$|We {{compared}} {{the distribution of}} GABAA and GABAB <b>binding</b> <b>sites</b> in the cochlear nucleus using quantitative receptor autoradiography with [3 H]GABA. To visualize GABAA <b>binding</b> <b>sites,</b> GABAB <b>binding</b> <b>sites</b> were blocked with +/-baclofen. To visualize GABAB <b>binding</b> <b>sites,</b> isoguvacine was used to block GABAA <b>binding</b> <b>sites.</b> GABAA <b>binding</b> <b>sites</b> predominated over GABAB, although there were marked regional differences {{in the distribution of}} binding. In the ventral cochlear nucleus, GABAA and GABAB <b>binding</b> <b>sites</b> were concentrated in the peripheral granule cell cap, with low binding levels in the central region. In the dorsal cochlear nucleus, binding was concentrated in the superficial (fusiform and molecular) layers, with a distinct laminar pattern. GABAA <b>binding</b> <b>sites</b> predominated in the fusiform cell layer. The molecular layer contained the highest level of GABAB <b>binding</b> <b>sites</b> in the entire cochlear nucleus. These results suggest that GABAergic inhibition in the cochlear nucleus is mediated both by GABAA and GABAB receptors, particularly in the dorsal cochlear nucleus. However, low levels of binding in areas such as the magnocellular regions of the ventral cochlear nucleus, known to contain abundant GABAergic synapses, suggest heterogeneity of GABA receptors in this auditory nucleus...|$|R
40|$|Abstract Background With {{the advent}} of {{increasing}} sequence and structural data, a number of methods have been proposed to locate putative protein <b>binding</b> <b>sites</b> from protein surfaces. Therefore, methods {{that are able to}} identify whether these <b>binding</b> <b>sites</b> interact are needed. Results We have developed a new method using a machine learning approach to detect if protein <b>binding</b> <b>sites,</b> once identified, interact with each other. The method exploits information relating to sequence and structural complementary across protein interfaces and has been tested on a non-redundant data set consisting of 584 homo-dimers and 198 hetero-dimers extracted from the PDB. Results indicate 87. 4 % of the interacting <b>binding</b> <b>sites</b> and 68. 6 % non-interacting <b>binding</b> <b>sites</b> were correctly identified. Furthermore, we built a pipeline that links this method to a modified version of our previously developed method that predicts the location of <b>binding</b> <b>sites.</b> Conclusion We have demonstrated that this high-throughput pipeline is capable of identifying <b>binding</b> <b>sites</b> for proteins, their interacting <b>binding</b> <b>sites</b> and, ultimately, their binding partners on a large scale. </p...|$|R
5|$|Additionally, genes {{can have}} {{regulatory}} regions many kilobases upstream or downstream {{of the open}} reading frame that alter expression. These act by binding to transcription factors which then cause the DNA to loop so that the regulatory sequence (and bound transcription factor) become close to the RNA polymerase <b>binding</b> <b>site.</b> For example, enhancers increase transcription by binding an activator protein which then helps to recruit the RNA polymerase to the promoter; conversely silencers bind repressor proteins and make the DNA less available for RNA polymerase.|$|E
5|$|Although {{many of the}} afore-mentioned inhibitors {{share the}} same Hsp90 <b>binding</b> <b>site</b> (either N- or C-terminal), {{it has been shown}} that some of these drugs {{preferentially}} access distinct Hsp90 populations, which are differentiated by the extent of their post-translational modification. Though no published inhibitor has yet to distinguish between Hsp90A and Hsp90B, a recent study has shown that phosphorylation of a particular residue in the Hsp90 N-terminus can provide isoform specificity to inhibitor binding., thus providing an additional level of regulation for optimal Hsp90 targeting.|$|E
5|$|Enzymes {{are usually}} {{much larger than}} their substrates. Sizes range from just 62 amino acid {{residues}}, for the monomer of 4-oxalocrotonate tautomerase, to over 2,500 residues in the animal fatty acid synthase. Only {{a small portion of}} their structure (around 2–4 amino acids) is directly involved in catalysis: the catalytic site. This catalytic site is located next to one or more binding sites where residues orient the substrates. The catalytic site and <b>binding</b> <b>site</b> together comprise the enzyme's active site. The remaining majority of the enzyme structure serves to maintain the precise orientation and dynamics of the active site.|$|E
40|$|Summary. FSH plus insulin, cortisol, and {{thyroxine}} (IFT) stimulated {{incorporation of}} dense isotope-containing (2 H, 13 C, 15 N) amino acids into soluble 125 I-labelled hCG <b>binding</b> <b>sites.</b> Evidence of new synthesis of <b>binding</b> <b>sites</b> appeared {{as early as}} 3 h after {{the beginning of the}} pulse-labelling period. By 48 h the majority of detectable soluble 125 I-labelled hCG <b>binding</b> <b>sites</b> appeared to be newly synthesized. Studies with FSH + IFT and puromycin indicated that FSH + IFT stimulated synthesis of new LH/hCG <b>binding</b> <b>sites,</b> and that internalization or degradation of LH/hCG <b>binding</b> <b>sites</b> may also require protein synthesis...|$|R
40|$|We {{previously}} {{proved that}} the positive rate of Griffonia simplicifolia agglutinin- 1 <b>binding</b> <b>sites</b> was increased by microwave irradiation (MWI). In this study, we applied MWI to improve the unstable staining pattern of four kinds of lectin. The positive rate on the apical surface was checked. By the conventional method, Amaranthus caudatus agglutinin (ACA) <b>binding</b> <b>sites</b> were positive in 1 / 6 carcinomas and Arachis hypogaea agglutinin (PNA) <b>binding</b> <b>sites,</b> in 3 / 6 carcinomas. In adenoma and non-neoplastic mucosa, neither ACA nor PNA <b>binding</b> <b>sites</b> were recognized. After MWI, ACA <b>binding</b> <b>sites</b> improved positively up to 3 / 6 in carcinomas, 4 / 6 in adenomas and 1 / 6 in non-neoplastic mucosa. PNA <b>binding</b> <b>sites</b> also improved positively up to 6 / 6 in carcinomas and 2 / 6 in adenomas, but remained negative in non-neoplastic mucosa. Vicia villosa agglutinin (VVA) <b>binding</b> <b>sites</b> were detected in 1 / 6 carcinomas by the conventional method, and increased up to 3 / 6 in carcinomas after MWI. VVA <b>binding</b> <b>sites</b> were recognized in neither adenoma nor non-neoplastic mucosa. By the conventional method, Umax flavus agglutinin (LFA) <b>binding</b> <b>sites</b> were positive in 1 / 6 carcinomas and non-neoplastic mucosa, respectively, but were negative in adenoma. After MWI, the positive rate increased up to 2 / 6 in carcinomas, 1 / 6 in adenomas and 1 / 6 in non-neoplastic mucosa. MWI was effective in improving the positive rate of <b>binding</b> <b>sites</b> of these lectins...|$|R
40|$|Abstract — Rat liver plasma {{membranes}} {{possess a}} single class of high affinity <b>binding</b> <b>sites</b> for the carbonyl-containing prostaglandins PGE 2 and PGE,. The specificity of the <b>binding</b> <b>sites</b> {{is confirmed by}} the effective competition of the corresponding unlabeled PGs with 'H-PGs for <b>binding</b> <b>sites</b> on receptors. The modification of liver plasma membranes by acetaldehyde drastically decreases {{the density of the}} <b>binding</b> <b>sites,</b> leaving unaffected the affinity of receptors. To bind PGF 2 a, liver plasma membranes have two types of <b>binding</b> <b>sites,</b> strong and weak ones. The alkylation of membranes by acetaldehyde does not essentially change the PGF 2 t< binding parameters. It is suggested that the protective effect of PGs in alcoholic liver injury occurs by their competition with acetaldehyde for <b>binding</b> <b>sites</b> on specific PG-binding receptors of liver plasma membranes...|$|R
5|$|Enzymes {{that contain}} a {{catalytic}} triad {{use it for}} one of two reaction types: either to split a substrate (hydrolases) or to transfer one portion of a substrate over to a second substrate (transferases). Triads are an inter-dependent set of residues in the active site of an enzyme and act in concert with other residues (e.g. <b>binding</b> <b>site</b> and oxyanion hole) to achieve nucleophilic catalysis. These triad residues act together to make the nucleophile member highly reactive, generating a covalent intermediate with the substrate that is then resolved to complete catalysis.|$|E
5|$|Many {{proteins}} {{are involved}} in the process of cell signaling and signal transduction. Some proteins, such as insulin, are extracellular proteins that transmit a signal from the cell in which they were synthesized to other cells in distant tissues. Others are membrane proteins that act as receptors whose main function is to bind a signaling molecule and induce a biochemical response in the cell. Many receptors have a <b>binding</b> <b>site</b> exposed on the cell surface and an effector domain within the cell, which may have enzymatic activity or may undergo a conformational change detected by other proteins within the cell.|$|E
5|$|Type I toxin-antitoxin systems {{rely on the}} base-pairing of {{complementary}} antitoxin RNA {{with the}} toxin's mRNA. Translation of the mRNA is then inhibited either by degradation via RNase III or by occluding the Shine-Dalgarno sequence or ribosome <b>binding</b> <b>site.</b> Often the toxin and antitoxin are encoded on opposite strands of DNA. The 5' or 3' overlapping region between the two genes is the area involved in complementary base-pairing, usually with between 19–23 contiguous base pairs.|$|E
40|$|The Protein Data Bank (PDB) {{contains}} {{the description of}} approximately 27, 000 protein-ligand <b>binding</b> <b>sites.</b> Most of the ligands at these sites are biologically active small molecules, affecting the biological function of the protein. Classifying their <b>binding</b> <b>sites</b> may lead to relevant results in drug discovery and design. Clusters of similar <b>binding</b> <b>sites</b> are created here by a hybrid, sequence and spatial-structure based approach, using the OPTICS clustering algorithm. We defined a dissimilarity-measure: a distance-function on the amino acid sequences of the <b>binding</b> <b>sites.</b> We clustered all the <b>binding</b> <b>sites</b> in PDB according to this distance function, {{and found that the}} clusters well characterize the EC codes of those entries that have one. The color-coded results, containing 20, 967 <b>binding</b> <b>sites</b> clustered, are available as html files in three parts a...|$|R
40|$|AbstractStructures {{of protein}} {{complexes}} provide atomistic insights into protein interactions. Human proteins represent {{a quarter of}} all structures in the Protein Data Bank; however, available protein complexes cover less than 10 % of the human proteome. Although it is theoretically possible to infer interactions in human proteins based on structures of homologous protein complexes, it is still unclear to what extent protein interactions and <b>binding</b> <b>sites</b> are conserved, and whether protein complexes from remotely related species can be used to infer interactions and <b>binding</b> <b>sites.</b> We considered biological units of protein complexes and clustered protein-protein <b>binding</b> <b>sites</b> into similarity groups based on their structure and sequence, which allowed us to identify unique <b>binding</b> <b>sites.</b> We showed that the growth rate of the number of unique <b>binding</b> <b>sites</b> in the Protein Data Bank was much slower than the growth rate of the number of structural complexes. Next, we investigated the evolutionary roots of unique <b>binding</b> <b>sites</b> and identified the major phyletic branches with the largest expansion in the number of novel <b>binding</b> <b>sites.</b> We found that many <b>binding</b> <b>sites</b> could be traced to the universal common ancestor of all cellular organisms, whereas relatively few <b>binding</b> <b>sites</b> emerged at the major evolutionary branching points. We analyzed the physicochemical properties of unique <b>binding</b> <b>sites</b> and found that the most ancient sites were the largest in size, involved many salt bridges, and were the most compact and least planar. In contrast, <b>binding</b> <b>sites</b> that appeared more recently in the evolution of eukaryotes were characterized by a larger fraction of polar and aromatic residues, and were less compact and more planar, possibly due to their more transient nature and roles in signaling processes...|$|R
40|$|Mammalian genomic {{imprinting}} is regulated by Imprinting Control Regions (ICRs) {{that are usually}} associated with tandem arrays of transcription factor <b>binding</b> <b>sites.</b> In the current study, the sequence features derived from a tandem array of YY 1 <b>binding</b> <b>sites</b> of Peg 3 -DMR (differentially methylated region) led us to identify three additional clustered YY 1 <b>binding</b> <b>sites,</b> which are also localized within the DMRs of Xist, Tsix, and Nespas. These regions {{have been shown to}} play a critical role as ICRs for the regulation of surrounding genes. These ICRs have maintained a tandem array of YY 1 <b>binding</b> <b>sites</b> during mammalian evolution. The in vivo binding of YY 1 to these regions is allele-specific and only to the unmethylated active alleles. Promoter/enhancer assays suggest that a tandem array of YY 1 <b>binding</b> <b>sites</b> function as a potential orientation-dependent enhancer. Insulator assays revealed that the enhancer-blocking activity is detected only in the YY 1 <b>binding</b> <b>sites</b> of Peg 3 -DMR but not in the YY 1 <b>binding</b> <b>sites</b> of other DMRs. Overall, our identification of three additional clustered YY 1 <b>binding</b> <b>sites</b> in imprinted domains suggests a significant role for YY 1 in mammalian {{genomic imprinting}}...|$|R
5|$|Nonbenzodiazepines are {{contraindicated}} during benzodiazepine withdrawal as {{they are}} cross tolerant with benzodiazepines and can induce dependence. Alcohol is also cross tolerant with benzodiazepines and more toxic and thus caution is needed to avoid replacing one dependence with another. During withdrawal, fluoroquinolone-based antibiotics are best avoided if possible; they displace benzodiazepines from their <b>binding</b> <b>site</b> and reduce GABA function and, thus, may aggravate withdrawal symptoms. Antipsychotics are not recommended for benzodiazepine withdrawal (or other CNS depressant withdrawal states) especially clozapine, olanzapine or low potency phenothiazines e.g. chlorpromazine as they lower the seizure threshold and can worsen withdrawal effects; if used extreme caution is required.|$|E
5|$|RNA {{thermometers}} {{are found}} in the 5' UTR of messenger RNA, upstream of a protein-coding gene. Here they are able to occlude the ribosome <b>binding</b> <b>site</b> (RBS) and prevent translation of the mRNA into protein. As temperature increases, the hairpin structure can 'melt' and expose the RBS or Shine-Dalgarno sequence to permit binding of the small ribosomal subunit (30S), which then assembles other translation machinery. The start codon, typically found 8 nucleotides downstream of the Shine-Dalgarno sequence, signals the beginning of a protein-coding gene which is then translated to a peptide product by the ribosome. In addition to this cis-acting mechanism, a lone example of a trans-acting RNA thermometer has been found in RpoS mRNA where it is thought {{to be involved in the}} starvation response.|$|E
5|$|Since a {{large number}} of oxidoreductases use NAD and NADH as substrates, and bind them using a highly conserved {{structural}} motif, the idea that inhibitors based on NAD could be specific to one enzyme is surprising. However, this can be possible: for example, inhibitors based on the compounds mycophenolic acid and tiazofurin inhibit IMP dehydrogenase at the NAD <b>binding</b> <b>site.</b> Because of the importance of this enzyme in purine metabolism, these compounds may be useful as anti-cancer, anti-viral, or immunosuppressive drugs. Other drugs are not enzyme inhibitors, but instead activate enzymes involved in NAD metabolism. Sirtuins are a particularly interesting target for such drugs, since activation of these NAD-dependent deacetylases extends lifespan. Compounds such as resveratrol increase the activity of these enzymes, which may be important in their ability to delay aging in both vertebrate, and invertebrate model organisms.|$|E
40|$|We {{introduce}} a non-parametric representation of transcription factor <b>binding</b> <b>sites</b> which can model arbitrary dependencies between positions. As two parameters are varied, this representation smoothly interpolates between the empirical distribution of <b>binding</b> <b>sites</b> {{and the standard}} position-specific scoring matrix (PSSM). In a test of generalization to unseen <b>binding</b> <b>sites</b> using 10 -fold cross-validation on known <b>binding</b> <b>sites</b> for 95 TRANSFAC transcription factors, this representation outperforms PSSMs on between 65 and 89 of the 95 transcription factors, depending on {{the choice of the}} two adjustable parameters. We also discuss how the non- parametric representation may be incorporated into frameworks for finding <b>binding</b> <b>sites</b> given only a collection of unaligned promoter regions...|$|R
40|$|The {{presence}} of specific <b>binding</b> <b>sites</b> for [125 I]-labelled hLH and hCG {{is described in}} Candida species. Binding was present in three strains of Candida albicans, and in Candida tropicalis, and was greatest in microsomes, though binding was also present in cytosol fractions. hLH and hCG mutually competed for these <b>binding</b> <b>sites.</b> Other hormones did not bind and did not compete for hLH <b>binding</b> <b>sites.</b> Scatchard plots showed two classes of <b>binding</b> <b>sites,</b> one with high affinity, low capacity {{and the other with}} lower affinity, high capacity binding in both microsomes and cytosol. This is the first report of specific <b>binding</b> <b>sites</b> for mammalian peptide hormones in a yeast...|$|R
50|$|The {{following}} is {{an analysis of the}} promoter region for FAM149A. It shows a number of transcription factor <b>binding</b> <b>sites</b> that may have strong contribution to regulating the genetic expression. The image below shows the locations of the <b>binding</b> <b>sites.</b> The <b>binding</b> <b>sites</b> were analyzed to find any possible unique functions.|$|R
5|$|The poly(A) tail {{acts as the}} <b>binding</b> <b>site</b> for poly(A)-binding protein. Poly(A)-binding protein {{promotes}} export {{from the}} nucleus and translation, and inhibits degradation. This protein binds to the poly(A) tail prior to mRNA export from the nucleus and in yeast also recruits poly(A) nuclease, an enzyme that shortens the poly(A) tail and allows the export of the mRNA. Poly(A)-binding protein is exported to the cytoplasm with the RNA. mRNAs that are not exported are degraded by the exosome. Poly(A)-binding protein also can bind to, and thus recruit, several proteins that affect translation, {{one of these is}} initiation factor-4G, which in turn recruits the 40S ribosomal subunit. However, a poly(A) tail is not required for the translation of all mRNAs. Further, poly(A) tailing (oligo-adenylation) can determine the fate of RNA molecules that are usually not poly(A)-tailed (such as (small) non-coding (sn)RNAs etc.) and thereby induce their RNA decay.|$|E
25|$|LeuT {{has been}} co-crystallised with {{sertraline}} and (R)- and (S)-fluoxetine where the SSRIs {{have been found}} to bind as non-competitive inhibitors in a vestibule <b>binding</b> <b>site</b> (can be looked at as a second <b>binding</b> <b>site),</b> which is separated from the drugs <b>binding</b> <b>site</b> by the site chains of the two aromatic amino acids of the extracellular gate of the transport protein. The halogens on the SSRIs chemical structure all bind to the same HBP within LeuT and interact with similar amino acids, but the amino acid sequence in the HBP is highly preserved between LeuT and SERT. That suggest that in the human SERT the SSRIs also bind both at the same position and with similar manner, which is a key feature making the SSRIs selective for SERT. Conversely, there could be differences in their binding where {{the other part of the}} drug molecule will likely bind to SERT in a different way, given the diversity in their structure. The localisation of the vestibular <b>binding</b> <b>site,</b> as the primary SSRI <b>binding</b> <b>site</b> in SERT is, is however controversial since some research has shown that the SSRIs work in competitive manner by binding to the drugs <b>binding</b> <b>site,</b> not to the second <b>binding</b> <b>site.</b>|$|E
25|$|Alcohol is {{classified}} as a sedative hypnotic drug. Alcohol produces a sedative effect by acting on receptors of the inhibitory neurotransmitter GABA. GABA receptors contain a <b>binding</b> <b>site</b> for the chemical, GABA, a chloride ion channel, and an additional <b>binding</b> <b>site</b> for alcohol molecules.|$|E
40|$|Benzodiazepine and GABA <b>binding</b> <b>sites</b> in the rat retina are {{influenced}} by a vitamin A-free diet. In rats fed a vitamin A-free diet, {{the total number of}} [3 H]GABA and [3 H]diazepam <b>binding</b> <b>sites</b> was markedly higher than in rats given a balanced diet. No differences were found in the apparent affinities of [3 H]GABA and [3 H]diazepam for their specific <b>binding</b> <b>sites.</b> The results suggest that GABA and benzodiazepine <b>binding</b> <b>sites</b> have a role in the function of the retina...|$|R
40|$|In this thesis, protein <b>binding</b> <b>sites</b> are considered. To {{enable the}} {{extraction}} of information from the space of protein <b>binding</b> <b>sites,</b> these <b>binding</b> <b>sites</b> must be mapped onto a mathematical space. This {{can be done by}} mapping <b>binding</b> <b>sites</b> onto vectors, graphs or point clouds. To finally enable a structure on the mathematical space, a distance measure is required, which is introduced in this thesis. This distance measure eventually can be used to extract information by means of data mining techniques...|$|R
5000|$|... is {{the ratio}} of the {{concentration}} of bound ligand to total available <b>binding</b> <b>sites,</b> and n is the number of <b>binding</b> <b>sites</b> per protein molecule.|$|R
